Spotlight
Partners
- Technology and Data
- Front End Sales and Marketing
- Allergy
- HIV
- Women's Health
- Migraine
- Compounding
- Continuous Glucose Monitoring
- Mental Health Awareness
- Veterinary Pharmacy
- CBD
- Infectious Disease
- Eye Health
- Digestive Health
- Biosimilars
- Influenza
- Shingles
- COPD Management
- Pediatrics
- Generics
- Pain Management
- COVID-19
- Immunization
- Oncology
- Anticoagulants
- Autoimmune Diseases
- Dermatology
- Diabetes
- Respiratory
- Heart Health
- Cardiovascular Clinical Consult
AstraZeneca's Purple Plus members offered savings on Nexium
AstraZeneca launches Nexium savings program for Purple Plus members
AstraZeneca announced enhancements to the Purple Plus program for patients with gastroesophageal reflux disease (GERD) who are prescribed Nexium (esomeprazole magnesium). This patient support program is designed to make Nexium more affordable for patients through instant rebates and to provide educational tools that can assist patients in staying adherent to their prescribed therapy. Patients can access on-line resources at
Related Videos
Related Content
